Atreca, Inc.
BCELDelisted Mar 20, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001532346
Atreca, Inc. was delisted on Mar 20, 2024; its insiders filed their last Form 4 on Apr 17, 2024; 43 institutions reported holding it in 13F filings for Q4 2023, worth $1.24M in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Atreca, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 80 | 65 | −15 |
| Shares | 16.6M | 16.0M | −663.9K (−4.0%) |
| Value | $29.8M | $25.1M | −$4.69M (−15.7%) |
New holders (3)
Institutions that held Atreca, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Gsa Capital Partners LLP | 191,442 | $301.0K | 0.04% |
| Global Trust Asset Management, LLC | 963 | $2.00K | 0.00% |
| Aquatic Capital Management LLC | 100 | $0 | 0.00% |
Sold out (18)
Institutions that held Atreca, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Susquehanna International Group, LLP | 44,926 | $80.0K |
| Marshall Wace, LLP | 26,839 | $48.0K |
| Cubist Systematic Strategies, LLC | 12,587 | $23.0K |
| Virtu Financial LLC | 10,422 | $19.0K |
| AQR Capital Management LLC | 10,211 | $18.0K |
| Two Sigma Securities, LLC | 10,027 | $18.0K |
| Atria Wealth Solutions, Inc. | 10,028 | $18.0K |
| Federated Hermes, Inc. | 6,191 | $11.0K |
| Tower Research Capital LLC (TRC) | 4,921 | $9.00K |
| Captrust Financial Advisors | 539 | $1.00K |
| Ellevest, Inc. | 316 | $1.00K |
| Ronald Blue Trust, Inc. | 281 | $1.00K |
| Howe & Rusling Inc | 50 | $0 |
| New York State Common Retirement Fund | 217 | $0 |
| Credit Suisse AG | 14 | $0 |
| Citigroup Inc | 263 | $0 |
| Aspire Private Capital, LLC | 200 | $0 |
| CoreCap Advisors, LLC | 100 | $0 |